World journal of gastrointestinal surgery · 2025
Evidence-based nursing to reduce polypharmacy risks in older cholecystectomy patients.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Deng Yu-Hua, Zeng Cai-Fang, Zhou Jing
Аннотация
BACKGROUND: With an aging society, older patients undergoing cholecystectomy often have multiple chronic diseases and require long-term multi-medication. Medication complexity significantly increases the risk of medication errors and adverse reactions, and effective nursing interventions are urgently required to ensure medication safety.
AIM: To investigate the efficacy of evidence-based nursing practices in mitigating polypharmacy risks among Suzhou Municipal Hospital Road Front Yard Area, thereby providing clinical guidance.
METHODS: The sixty older patients who underwent cholecystectomy between September 2024 and September 2025 treated with polypharmacy were enrolled. Using random number tables, hey were divided into study and control groups (n = 30 each), who received routine medication nursing and evidence-based nursing, respectively. Pre-intervention and post-intervention comparisons were made between groups for medication knowledge, competence, and adherence scores. The incidences of duplicate medications, missed doses, self-discontinuation, unauthorized alterations, schedule changes, and adverse reaction rates assessed potential medication risks.
RESULTS: Both the study and control groups showed significant increases in medication knowledge, management competence, and adherence scores after intervention (all P < 0.05). The study group had higher post-intervention scores (medication knowledge: 87.29 ± 5.09 vs 70.62 ± 5.38; medication management competence: 63.22 ± 3.11 vs 56.19 ± 4.08; medication adherence: 7.13 ± 1.04 vs 6.05 ± 1.03, all P < 0.05). The incidence of duplicate medication, missed doses, self-discontinuation, unauthorized dose alterations, and schedule modifications decreased in both groups post-intervention (all P < 0.05), with lower rates in the study group (duplicate medication: 13.33% vs 30.0%; missed doses: 10.0% vs 26.67%; all P < 0.05). The study group had a lower adverse reaction rate (3.33% vs 26.67%, P < 0.05) and more patients with potential medication hazard level 0 (83.33% vs 53.33%), while fewer patients had level 2 and 3 hazards (3.33% vs 16.67% and 0% vs 10.00%, respectively; all P < 0.05).
CONCLUSION: Evidence-based nursing for polypharmacy risks in older adults undergoing cholecystectomy can enhance medication awareness, improve management and adherence, reduce adverse behaviors, and lower adverse reactions and hazard levels.
AIM: To investigate the efficacy of evidence-based nursing practices in mitigating polypharmacy risks among Suzhou Municipal Hospital Road Front Yard Area, thereby providing clinical guidance.
METHODS: The sixty older patients who underwent cholecystectomy between September 2024 and September 2025 treated with polypharmacy were enrolled. Using random number tables, hey were divided into study and control groups (n = 30 each), who received routine medication nursing and evidence-based nursing, respectively. Pre-intervention and post-intervention comparisons were made between groups for medication knowledge, competence, and adherence scores. The incidences of duplicate medications, missed doses, self-discontinuation, unauthorized alterations, schedule changes, and adverse reaction rates assessed potential medication risks.
RESULTS: Both the study and control groups showed significant increases in medication knowledge, management competence, and adherence scores after intervention (all P < 0.05). The study group had higher post-intervention scores (medication knowledge: 87.29 ± 5.09 vs 70.62 ± 5.38; medication management competence: 63.22 ± 3.11 vs 56.19 ± 4.08; medication adherence: 7.13 ± 1.04 vs 6.05 ± 1.03, all P < 0.05). The incidence of duplicate medication, missed doses, self-discontinuation, unauthorized dose alterations, and schedule modifications decreased in both groups post-intervention (all P < 0.05), with lower rates in the study group (duplicate medication: 13.33% vs 30.0%; missed doses: 10.0% vs 26.67%; all P < 0.05). The study group had a lower adverse reaction rate (3.33% vs 26.67%, P < 0.05) and more patients with potential medication hazard level 0 (83.33% vs 53.33%), while fewer patients had level 2 and 3 hazards (3.33% vs 16.67% and 0% vs 10.00%, respectively; all P < 0.05).
CONCLUSION: Evidence-based nursing for polypharmacy risks in older adults undergoing cholecystectomy can enhance medication awareness, improve management and adherence, reduce adverse behaviors, and lower adverse reactions and hazard levels.